- Home
- Equipment
- usa massachusetts
- inflammatory response
Show results for
Refine by
Inflammatory Response Equipment Supplied In Usa Massachusetts
5 equipment items found
Manufactured by:Peters Surgical based inBoulogne-Billancourt, FRANCE
FEATURES: Promesh® SURG LI is a light-weight mesh design with polypropylene monofilaments large pores to ensure fibrosis and tissue integration. The light-weight structure aligned with a reduced quantity of implanted material will influence the inflammatory reaction and patient post-operative pain. Promesh® SURG LI is cutable and designed for extraperitoneal use only. All Promesh®SURG ...
by:Aegle Therapeutics based inWoburn, MASSACHUSETTS (USA)
Advancement of extracellular vesicle therapy to the patient has been hampered by an inability to isolate extracellular vesicles in useful quantities while preserving their structural and functional integrity. EVs derived from MSCs enjoy the same immunosuppressant characteristics of their parent cells. However, when EVs are processed incorrectly, they can trigger an adverse inflammation response ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
AV-380 is AVEO’s first-in-class, potent, humanized inhibitory IgG1 antibody targeting growth differentiation factor 15 (GDF15). GDF15 is a pro-inflammatory cytokine whose elevated circulating levels have been correlated with cachexia in cachectic cancer patients and several animal models of cancer cachexia. Current evidence suggests that a pro-inflammatory ...
Manufactured by:AOBiome Therapeutic, LLC based inCambridge, MASSACHUSETTS (USA)
The human microbiome consists of hundreds of trillions of microorganisms, outnumbering human cells by 10 to 1 with as many as 3 million bacterial genes to our approximately 20 thousand. While the microbiome has recently become an area of active research, its overall effects on human health remain largely ...
Manufactured by:Biotest AG based inDreieich, GERMANY
Trimodulin mediates its mode of action via three potential mechanisms which are; opsonization of causal pathogens, neutralizing of microbial pathogens and their virulence factors (endo- and exotoxins) and targeting the host inflammatory response (anti-inflammatory properties). Currently, trimodulin is under clinical development for severe ...